In a Controlled Human Infection Model (CHIM) study, a well-characterised strain of an infectious agent is given to carefully selected adult volunteers in order to better understand human diseases, how they spread, and find new ways to prevent and treat them. These studies play a vital role in helping to develop vaccines and treatments for infectious diseases.

A very important application of the se studies are the field of malaria clinical research. Indeed in the Controlled human malaria infection (CHMI) studies, healthy volunteers are infected with Plasmodium falciparum to assess the efficacy of novel malaria vaccines and drugs, becoming a vital tool to accelerate vaccine and drug development.

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

The COVID-19 pandemic threatens to reverse recent progress in reducing the global burden of Tuberculosis

The COVID-19 pandemic threatens to reverse recent progress in reducing the global burden of tuberculosis. The global number of deaths for tuberculosis could increase by around 200.000–400.000 in 2020 alone,

African-European Symposium: Challenges in Research Ethics Assessment, 13:00 – 18:00 CET, May 25th, 2021.

The symposium,  organised by The Embassy of Good Science, in collaboration with EUREC, BERC-Luso, AfriEthique, and LiberHetica, aims to facilitate the sharing of experiences and perspectives on research ethics assessment challenges between African and

Second European-African training for the Congolese team on “SARS-CoV-2 detection by ApoH enzyme”

As part of the implementation of ITAIL-COVID-19 project funded by the European Development Countries Partnership for Clinical Trials (EDCTP) and coordinated by the Congolese Foundation for Medical Research (FCRM), the